Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AS-OCT in Acquired Punctal Stenosis
NCT04318652Phase 4Completed
- Sponsor
- Tanta University
- Start
- Sep 2018
- Primary completion
- Sep 2019
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 4, open-label trial of methylprednisolone in acquired punctal stenosis (APS) (2 arms), sponsored by Tanta University. Primary endpoint: punctal opening at 1 month. Started Sep 2018; status: completed.
02
Drugs
methylprednisolone
03
Conditions
acquired punctal stenosis (APS)
Beyond the preview
Go deeper on NCT04318652.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04318652.